Array-818-202 for Non-small Cell Lung Cancer - Clinical Trial
What is the Purpose of this Study?
We are doing this study to learn about the safety and effectiveness of the study drugs (Encorafenib and Binimetinib) in patients.
Non-Small Cell Lung Cancer (NSCLC)
Who Can Participate in the Study?
Adults 19 years or older with NSCLC with a gene called BRAFV600E that has mutated.
What is Involved?
If you choose to join this study, you will:
-Be in the study up to 2 years
-Take study drugs daily
-Give blood samples
-Possible give a small lung tissue sample
-Continue with your regular care